BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15992352)

  • 1. Anti-cancer potential of sesquiterpene lactones: bioactivity and molecular mechanisms.
    Zhang S; Won YK; Ong CN; Shen HM
    Curr Med Chem Anticancer Agents; 2005 May; 5(3):239-49. PubMed ID: 15992352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What made sesquiterpene lactones reach cancer clinical trials?
    Ghantous A; Gali-Muhtasib H; Vuorela H; Saliba NA; Darwiche N
    Drug Discov Today; 2010 Aug; 15(15-16):668-78. PubMed ID: 20541036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sesquiterpene lactones as drugs with multiple targets in cancer treatment: focus on parthenolide.
    Kreuger MR; Grootjans S; Biavatti MW; Vandenabeele P; D'Herde K
    Anticancer Drugs; 2012 Oct; 23(9):883-96. PubMed ID: 22797176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives on sesquiterpene lactones in inflammation and cancer.
    Merfort I
    Curr Drug Targets; 2011 Oct; 12(11):1560-73. PubMed ID: 21561425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of oxidative stress in anticancer activity of sesquiterpene lactones.
    Gach K; Długosz A; Janecka A
    Naunyn Schmiedebergs Arch Pharmacol; 2015 May; 388(5):477-86. PubMed ID: 25656627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemopreventive activity of sesquiterpene lactones (SLs) from yacon against TPA-induced Raji cells deformation.
    Siriwan D; Miyawaki C; Miyamoto T; Naruse T; Okazaki K; Tamura H
    Pak J Biol Sci; 2011 May; 14(10):605-9. PubMed ID: 22097098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances on Cytotoxic Sesquiterpene Lactones.
    Quintana J; Estévez F
    Curr Pharm Des; 2018; 24(36):4355-4361. PubMed ID: 30659534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of sesquiterpene lactone: A new promising way for cancer therapy based on anticancer activity.
    Babaei G; Aliarab A; Abroon S; Rasmi Y; Aziz SG
    Biomed Pharmacother; 2018 Oct; 106():239-246. PubMed ID: 29966966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons learned from the discovery and development of the sesquiterpene lactones in cancer therapy and prevention.
    Cheikh IA; El-Baba C; Youssef A; Saliba NA; Ghantous A; Darwiche N
    Expert Opin Drug Discov; 2022 Dec; 17(12):1377-1405. PubMed ID: 36373806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity and mechanism of costunolide and dehydrocostus lactone: Two natural sesquiterpene lactones from the Asteraceae family.
    Li Q; Wang Z; Xie Y; Hu H
    Biomed Pharmacother; 2020 May; 125():109955. PubMed ID: 32014691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Methylene-γ-lactones as a novel class of anti-leukemic agents.
    Gach K; Janecka A
    Anticancer Agents Med Chem; 2014 Jun; 14(5):688-94. PubMed ID: 24628266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of transcription factor NF-kappaB by sesquiterpene lactones: a proposed molecular mechanism of action.
    Rüngeler P; Castro V; Mora G; Gören N; Vichnewski W; Pahl HL; Merfort I; Schmidt TJ
    Bioorg Med Chem; 1999 Nov; 7(11):2343-52. PubMed ID: 10632044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antileukemic Properties of Sesquiterpene Lactones: A Systematic Review.
    da Silva Castro E; Alves Antunes LA; Revoredo Lobo JF; Ratcliffe NA; Borges RM; Rocha L; Burth P; Fonte Amorim LM
    Anticancer Agents Med Chem; 2018; 18(3):323-334. PubMed ID: 28925880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total sesquiterpene lactones prepared from Inula helenium L. has potentials in prevention and therapy of rheumatoid arthritis.
    Gao S; Wang Q; Tian XH; Li HL; Shen YH; Xu XK; Wu GZ; Hu ZL; Zhang WD
    J Ethnopharmacol; 2017 Jan; 196():39-46. PubMed ID: 27988396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Anticancer Agents from Plant-Derived Sesquiterpene Lactones.
    Ren Y; Yu J; Kinghorn AD
    Curr Med Chem; 2016; 23(23):2397-420. PubMed ID: 27160533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-Activity Relationships of Cytotoxic Lactones as Inhibitors and Mechanisms of Action.
    Torrens F; Castellano G
    Curr Drug Discov Technol; 2020; 17(2):166-182. PubMed ID: 30621564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vernolide-A and Vernodaline: Sesquiterpene Lactones with Cytotoxicity against Cancer.
    Nguyen NH; Nguyen MT; Little PJ; Do AT; Tran PT; Vo XN; Do BH
    J Environ Pathol Toxicol Oncol; 2020; 39(4):299-308. PubMed ID: 33389902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of sesquiterpene lactones from Milleria quinqueflora on their anti-inflammatory activity using the transcription factor NF-kappa B as molecular target.
    Castro V; Rüngeler P; Murillo R; Hernandez E; Mora G; Pahl HL; Merfort I
    Phytochemistry; 2000 Jan; 53(2):257-63. PubMed ID: 10680180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of inflammatory cytokine production and lymphocyte proliferation by structurally different sesquiterpene lactones correlates with their effect on activation of NF-kappaB.
    Koch E; Klaas CA; Rüngeler P; Castro V; Mora G; Vichnewski W; Merfort I
    Biochem Pharmacol; 2001 Sep; 62(6):795-801. PubMed ID: 11551526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative structure-activity relationship of sesquiterpene lactones as inhibitors of the transcription factor NF-kappaB.
    Siedle B; García-Piñeres AJ; Murillo R; Schulte-Mönting J; Castro V; Rüngeler P; Klaas CA; Da Costa FB; Kisiel W; Merfort I
    J Med Chem; 2004 Nov; 47(24):6042-54. PubMed ID: 15537359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.